Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes: Overlapping specificities to phogrin and ICA512/IA-2

Diabetes

Volumn 45, Issue 10, 1996, Pages 1344-1349

  Kawasaki, Eiji ^a   Eisenbarth, George S ^a   Wasmeier, Christina ^b   Hutton, John C ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MEMBRANE PROTEIN; PHOSPHATASE; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR CLONING; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY;

EID: 0029784457     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.10.1344     Document Type: Article

References (20)

1. Eisenbarth GS, Ziegler A, Colman P: Pathogenesis of insulin-dependent (type I) diabetes mellitus. In Joslin's Diabetes Mellitus. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994, p. 216-239
2. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
3. Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De-Camilli P: Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
4. Dotta F, Previti M, Lenti L, Dionisi S, Casetta B, D'Erme M, Eisenbarth GS, DiMario U: GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia 38:1117-1121, 1995
5. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL: Distinct antibody specificities to a 64-kD islet cell antigen in type I diabetes as revealed by trypsin treatment. J Exp Med 172:789-794, 1990
6. Christie MR, Tun RYM, Lo SSS, Cassidy D, Brown TJ, Hollands J, Shattock M, Bottazzo GF, Leslie RDG: Antibodies to GAD and tryptic fragments of islet 64k antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes 41:782-787, 1992
7. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF: Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254-1259, 1994
8. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
9. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Gold-stein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
10. Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514, 1994
11. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511, 1995
12. Wasmeier C, Hutton J: Molecular cloning of phogrin, a homologue localized to insulin secretory granule membranes. J Biol Chem 271:18161-18170, 1996
13. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
14. Gianani R, Rabin D, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GS: ICA512 autoantibody radioassay. Diabetes 44:1340-1344, 1995
15. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelesen B, Lernmark Å: A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350, 1994
16. Vardi P, Dib SA, Tuttleman M, Connelly E, Grinbergs M, Radizabeh A, Riley WJ, Maclaren NK, Eisenbarth GS, Soeldner JS: Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 36:1286-1291, 1987
17. Ongagna JC, Levy-Marchal: Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies. Diabetologia 38:370-375, 1995
18. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
19. Hagopian WA, Michelesen B, Karlsen AE, Larsen F, Moody A, Grubin CE, Rowe R, Petersen JS, McEvoy R, Lernmark A: Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42:631-636, 1993
20. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS: Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 93:2307-2311, 1996